Astellas Pharma Inc (OTCPK:ALPMF)
$ 11.1275 0 (0%) Market Cap: 20.04 Bil Enterprise Value: 23.95 Bil PE Ratio: 56.39 PB Ratio: 2.01 GF Score: 87/100

Astellas Pharma Inc Fezolinetant Briefing Transcript

Oct 17, 2022 / 12:30AM GMT
Release Date Price: $12.95 (-4.07%)
Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations

[Interpreted] Thank you very much for joining out of your very busy schedule today. I'm delighted to serve as emcee today. I'm Ikeda from Corporate Advocacy and Relations. Thank you for your time. You can join this meeting through Zoom webinar or live streaming. After our explanation, we will go to a Q&A session. You can ask questions only through Zoom webinar. You cannot ask questions through live streaming.

Today, we have simultaneous interpreting in Japanese and English. If you are joining from Zoom webinar, you can choose the language of your preference from the Zoom screen menu. And presentation materials are not posted on our website. If you want to get one, please contact the IR department.

Today's presenters are Executive Director, Global Development Project Leader, Dr. Marci English; and Senior Vice President and Head, Medical Specialties, Global Strategic Brand Marketing, Dr. Txema Sanz. The Q&A session will be joined by Dr. Andrew Krivoshik, Divisional President and Head of Development

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot